Article

AAO initiates EyeSmart program to educate about eye disease

San Francisco ̬ The risk of age-related eye disease is one that Americans do not realize according to a national health survey conducted by the American Academy of Ophthalmology (AAO). The AAO is issuing a new public initiative in response called EyeSmart to educate Americans about the risks they face.

San Francisco - The risk of age-related eye disease is one that Americans do not realize according to a national health survey conducted by the American Academy of Ophthalmology (AAO). The AAO is issuing a new public initiative in response called EyeSmart to educate Americans about the risks they face.

Only 11% of Americans find themselves at high risk for eye disease according to a survey conducted by Greenberg Quinlan Rosner Research. Americans over the age of 65 are the most at risk, however, only 10% believe they are at risk.

Age-related eye diseases such as cataract, diabetic retinopathy, glaucoma, and age-related macular degeneration are expected to increase from 28 million to 43 million by the year 2020, according to the organization. Americans are more concerned with weight gain and joint and back pain then they are with vision loss.

It is by recommendation of the AAO that adults with no signs or risk factors for eye disease get a baseline eye disease screening at age 40. For people with a family history of eye disease, diabetes or high blood pressure they should consult their doctor to determine how often an examination is needed.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.